BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3668297)

  • 21. Covalent cross-linking of radiolabeled N-formylated hexapeptide to its specific receptor on rat and human neutrophils: evidence for a ligand induced complex formation.
    Remes J; Keinänen K; Petäjä-Repo U; Rajaniemi H
    J Recept Res; 1992; 12(4):507-27. PubMed ID: 1460606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
    He R; Tan L; Browning DD; Wang JM; Ye RD
    J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cytochalasin B to distinguish between early and late events in neutrophil activation.
    Bennett JP; Cockcroft S; Gomperts BD
    Biochim Biophys Acta; 1980 Oct; 601(3):584-91. PubMed ID: 6251879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of ligand-receptor complexes with actin filaments in human neutrophils: a possible regulatory role for a G-protein.
    Särndahl E; Lindroth M; Bengtsson T; Fällman M; Gustavsson J; Stendahl O; Andersson T
    J Cell Biol; 1989 Dec; 109(6 Pt 1):2791-9. PubMed ID: 2512299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
    Gardner JP; Melnick DA; Malech HL
    J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of N-formyl-methionyl-leucyl-phenylalanine receptor recycling by surface membrane neutral endopeptidase-mediated degradation of ligand.
    Painter RG; Aiken ML
    J Leukoc Biol; 1995 Oct; 58(4):468-76. PubMed ID: 7561524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Mg2+ control of formyl-peptide-receptor--G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein.
    Gierschik P; Steisslinger M; Sidiropoulos D; Herrmann E; Jakobs KH
    Eur J Biochem; 1989 Jul; 183(1):97-105. PubMed ID: 2502402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils.
    Klotz KN; Krotec KL; Gripentrog J; Jesaitis AJ
    J Immunol; 1994 Jan; 152(2):801-10. PubMed ID: 8283053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of formylpeptide chemoattractant binding on neutrophils and monocytes from patients with head and neck cancer.
    Walter RJ; Danielson JR
    J Natl Cancer Inst; 1987 Jan; 78(1):61-9. PubMed ID: 3467131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NADPH-oxidase activation in murine neutrophils via formyl peptide receptors.
    Bylund J; Samuelsson M; Collins LV; Karlsson A
    Exp Cell Res; 2003 Jan; 282(2):70-7. PubMed ID: 12531693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
    Bonora GM; Toniolo C; Freer RJ; Becker EL
    Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct visualization of formylpeptide receptor binding on rounded and polarized human neutrophils: cellular and receptor heterogeneity.
    Walter RJ; Marasco WA
    J Leukoc Biol; 1987 May; 41(5):377-91. PubMed ID: 3553401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
    Marasco WA; Feltner DE; Ward PA
    J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.